Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Analysis and Use of the Emotional Context with Wearable Devices for Games and Intelligent Assistants.

Nalepa GJ, Kutt K, Giżycka B, Jemioło P, Bobek S.

Sensors (Basel). 2019 May 31;19(11). pii: E2509. doi: 10.3390/s19112509.

2.

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study.

Rogers ZR, Nakano TA, Olson TS, Bertuch AA, Wang W, Gillio A, Coates TD, Chawla A, Castillo P, Kurre P, Gamper C, Bennett CM, Joshi S, Geddis AE, Boklan J, Nalepa G, Rothman JA, Huang JN, Kupfer GM, Cada M, Glader B, Walkovich KJ, Thompson AA, Hanna R, Vlachos A, Malsch M, Weller EA, Williams DA, Shimamura A.

Haematologica. 2019 Apr 4. pii: haematol.2018.206540. doi: 10.3324/haematol.2018.206540. [Epub ahead of print]

3.

A tired young man with a dysmorphic thumb.

Nalepa G.

BMJ. 2018 Nov 22;363:k4528. doi: 10.1136/bmj.k4528. No abstract available.

PMID:
30467112
4.

A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomas.

Gehlhausen JR, Hawley E, Wahle BM, He Y, Edwards D, Rhodes SD, Lajiness JD, Staser K, Chen S, Yang X, Yuan J, Li X, Jiang L, Smith A, Bessler W, Sandusky G, Stemmer-Rachamimov A, Stuhlmiller TJ, Angus SP, Johnson GL, Nalepa G, Yates CW, Wade Clapp D, Park SJ.

Hum Mol Genet. 2019 Feb 15;28(4):572-583. doi: 10.1093/hmg/ddy361.

PMID:
30335132
5.

Whole-exome sequencing enables correct diagnosis and surgical management of rare inherited childhood anemia.

Khurana M, Edwards D, Rescorla F, Miller C, He Y, Sierra Potchanant E, Nalepa G.

Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). pii: a003152. doi: 10.1101/mcs.a003152. Print 2018 Oct.

6.

Fanconi anaemia and cancer: an intricate relationship.

Nalepa G, Clapp DW.

Nat Rev Cancer. 2018 Mar;18(3):168-185. doi: 10.1038/nrc.2017.116. Epub 2018 Jan 29. Review.

PMID:
29376519
7.

Correction for Sierra Potchanant et al., "INPP5E Preserves Genomic Stability through Regulation of Mitosis".

Sierra Potchanant EA, Cerabona D, Sater ZA, He Y, Sun Z, Gehlhausen J, Schurmans S, Gayral S, Nalepa G.

Mol Cell Biol. 2017 Sep 26;37(20). pii: e00389-17. doi: 10.1128/MCB.00389-17. Print 2017 Oct 15. No abstract available.

8.

Chronic steroid-response pancytopenia and increased bone density due to thromboxane synthase deficiency.

Sharma R, Sierra Potchanant E, Schwartz JE, Nalepa G.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26777. Epub 2017 Sep 4.

PMID:
28868793
9.

An abnormal bone marrow microenvironment contributes to hematopoietic dysfunction in Fanconi anemia.

Zhou Y, He Y, Xing W, Zhang P, Shi H, Chen S, Shi J, Bai J, Rhodes SD, Zhang F, Yuan J, Yang X, Zhu X, Li Y, Hanenberg H, Xu M, Robertson KA, Yuan W, Nalepa G, Cheng T, Clapp DW, Yang FC.

Haematologica. 2017 Jun;102(6):1017-1027. doi: 10.3324/haematol.2016.158717. Epub 2017 Mar 24.

10.

INPP5E Preserves Genomic Stability through Regulation of Mitosis.

Sierra Potchanant EA, Cerabona D, Sater ZA, He Y, Sun Z, Gehlhausen J, Nalepa G.

Mol Cell Biol. 2017 Mar 1;37(6). pii: e00500-16. doi: 10.1128/MCB.00500-16. Print 2017 Mar 15. Erratum in: Mol Cell Biol. 2017 Sep 26;37(20):. Schurmans, Stéphane [added]; Gayral, Stéphanie [added].

11.

IL-4 impairs wound healing potential in the skin by repressing fibronectin expression.

Serezani APM, Bozdogan G, Sehra S, Walsh D, Krishnamurthy P, Sierra Potchanant EA, Nalepa G, Goenka S, Turner MJ, Spandau DF, Kaplan MH.

J Allergy Clin Immunol. 2017 Jan;139(1):142-151.e5. doi: 10.1016/j.jaci.2016.07.012. Epub 2016 Aug 20.

12.

Evaluation and Management of Chronic Pancytopenia.

Sharma R, Nalepa G.

Pediatr Rev. 2016 Mar;37(3):101-111; quiz 112-3. doi: 10.1542/pir.2014-0087. Review. No abstract available.

13.

Leukemia and chromosomal instability in aged Fancc-/- mice.

Cerabona D, Sun Z, Nalepa G.

Exp Hematol. 2016 May;44(5):352-7. doi: 10.1016/j.exphem.2016.01.009. Epub 2016 Feb 6.

14.

A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.

Zucker J, Temm C, Czader M, Nalepa G.

Pediatr Blood Cancer. 2016 May;63(5):917-21. doi: 10.1002/pbc.25871. Epub 2015 Dec 29.

15.

FANCA safeguards interphase and mitosis during hematopoiesis in vivo.

Abdul-Sater Z, Cerabona D, Potchanant ES, Sun Z, Enzor R, He Y, Robertson K, Goebel WS, Nalepa G.

Exp Hematol. 2015 Dec;43(12):1031-1046.e12. doi: 10.1016/j.exphem.2015.08.013. Epub 2015 Sep 11.

16.

Pathophysiological role of microRNA-29 in pancreatic cancer stroma.

Kwon JJ, Nabinger SC, Vega Z, Sahu SS, Alluri RK, Abdul-Sater Z, Yu Z, Gore J, Nalepa G, Saxena R, Korc M, Kota J.

Sci Rep. 2015 Jun 22;5:11450. doi: 10.1038/srep11450.

17.

Cyclin E-CDK2 protein phosphorylates plant homeodomain finger protein 8 (PHF8) and regulates its function in the cell cycle.

Sun L, Huang Y, Wei Q, Tong X, Cai R, Nalepa G, Ye X.

J Biol Chem. 2015 Feb 13;290(7):4075-85. doi: 10.1074/jbc.M114.602532. Epub 2014 Dec 29.

18.

A critical role of CDKN3 in Bcr-Abl-mediated tumorigenesis.

Chen Q, Chen K, Guo G, Li F, Chen C, Wang S, Nalepa G, Huang S, Chen JL.

PLoS One. 2014 Oct 31;9(10):e111611. doi: 10.1371/journal.pone.0111611. eCollection 2014.

19.

A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.

Gehlhausen JR, Park SJ, Hickox AE, Shew M, Staser K, Rhodes SD, Menon K, Lajiness JD, Mwanthi M, Yang X, Yuan J, Territo P, Hutchins G, Nalepa G, Yang FC, Conway SJ, Heinz MG, Stemmer-Rachamimov A, Yates CW, Wade Clapp D.

Hum Mol Genet. 2015 Jan 1;24(1):1-8. doi: 10.1093/hmg/ddu414. Epub 2014 Aug 11.

20.

Fanconi anemia and the cell cycle: new perspectives on aneuploidy.

Nalepa G, Clapp DW.

F1000Prime Rep. 2014 Apr 1;6:23. doi: 10.12703/P6-23. eCollection 2014. Review.

21.

Fanconi anemia signaling network regulates the spindle assembly checkpoint.

Nalepa G, Enzor R, Sun Z, Marchal C, Park SJ, Yang Y, Tedeschi L, Kelich S, Hanenberg H, Clapp DW.

J Clin Invest. 2013 Sep;123(9):3839-47. doi: 10.1172/JCI67364. Epub 2013 Aug 15.

22.

The tumor suppressor CDKN3 controls mitosis.

Nalepa G, Barnholtz-Sloan J, Enzor R, Dey D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, Chen S, Guan X, Chen Y, Renbarger J, Yang FC, Parada LF, Clapp W.

J Cell Biol. 2013 Jun 24;201(7):997-1012. doi: 10.1083/jcb.201205125. Epub 2013 Jun 17. Erratum in: J Cell Biol. 2013 Aug 19;202(4):717.

23.

Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.

Staser K, Park SJ, Rhodes SD, Zeng Y, He YZ, Shew MA, Gehlhausen JR, Cerabona D, Menon K, Chen S, Sun Z, Yuan J, Ingram DA, Nalepa G, Yang FC, Clapp DW.

J Clin Invest. 2013 Jan;123(1):329-34. doi: 10.1172/JCI66167. Epub 2012 Dec 10.

24.

Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Robertson KA, Nalepa G, Yang FC, Bowers DC, Ho CY, Hutchins GD, Croop JM, Vik TA, Denne SC, Parada LF, Hingtgen CM, Walsh LE, Yu M, Pradhan KR, Edwards-Brown MK, Cohen MD, Fletcher JW, Travers JB, Staser KW, Lee MW, Sherman MR, Davis CJ, Miller LC, Ingram DA, Clapp DW.

Lancet Oncol. 2012 Dec;13(12):1218-24. doi: 10.1016/S1470-2045(12)70414-X. Epub 2012 Oct 23.

25.

The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.

Wu X, Chen S, He Y, Rhodes SD, Mohammad KS, Li X, Yang X, Jiang L, Nalepa G, Snider P, Robling AG, Clapp DW, Conway SJ, Guise TA, Yang FC.

PLoS One. 2011;6(9):e24917. doi: 10.1371/journal.pone.0024917. Epub 2011 Sep 29.

26.

Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.

Pulliam-Leath AC, Ciccone SL, Nalepa G, Li X, Si Y, Miravalle L, Smith D, Yuan J, Li J, Anur P, Orazi A, Vance GH, Yang FC, Hanenberg H, Bagby GC, Clapp DW.

Blood. 2010 Oct 21;116(16):2915-20. doi: 10.1182/blood-2009-08-240747. Epub 2010 Jul 6.

27.

The tumor suppressor CYLD regulates entry into mitosis.

Stegmeier F, Sowa ME, Nalepa G, Gygi SP, Harper JW, Elledge SJ.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8869-74. Epub 2007 May 10.

28.

Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities.

Stegmeier F, Rape M, Draviam VM, Nalepa G, Sowa ME, Ang XL, McDonald ER 3rd, Li MZ, Hannon GJ, Sorger PK, Kirschner MW, Harper JW, Elledge SJ.

Nature. 2007 Apr 19;446(7138):876-81.

PMID:
17443180
29.

A functional genomic screen identifies a role for TAO1 kinase in spindle-checkpoint signalling.

Draviam VM, Stegmeier F, Nalepa G, Sowa ME, Chen J, Liang A, Hannon GJ, Sorger PK, Harper JW, Elledge SJ.

Nat Cell Biol. 2007 May;9(5):556-64. Epub 2007 Apr 8.

PMID:
17417629
30.

Drug discovery in the ubiquitin-proteasome system.

Nalepa G, Rolfe M, Harper JW.

Nat Rev Drug Discov. 2006 Jul;5(7):596-613. Review.

PMID:
16816840
31.
32.

Recognition of phosphodegron motifs in human cyclin E by the SCF(Fbw7) ubiquitin ligase.

Ye X, Nalepa G, Welcker M, Kessler BM, Spooner E, Qin J, Elledge SJ, Clurman BE, Harper JW.

J Biol Chem. 2004 Nov 26;279(48):50110-9. Epub 2004 Sep 13.

33.

Visualization of a highly organized intranuclear network of filaments in living mammalian cells.

Nalepa G, Harper JW.

Cell Motil Cytoskeleton. 2004 Oct;59(2):94-108.

PMID:
15362113
34.

SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.

Jin J, Shirogane T, Xu L, Nalepa G, Qin J, Elledge SJ, Harper JW.

Genes Dev. 2003 Dec 15;17(24):3062-74. Epub 2003 Dec 17.

36.

Therapeutic anti-cancer targets upstream of the proteasome.

Nalepa G, Wade Harper J.

Cancer Treat Rev. 2003 May;29 Suppl 1:49-57. Review.

PMID:
12738243
37.

Efp: a ring of independence?

Nalepa G, Harper JW.

Nat Med. 2002 Jul;8(7):661-2. No abstract available.

PMID:
12091896
38.

[Caspases and apoptosis: die and let live].

Nalepa G, Zukowska-Szczechowska E.

Wiad Lek. 2002;55(1-2):100-6. Review. Polish.

PMID:
12043304

Supplemental Content

Loading ...
Support Center